Remove Gerontology Remove Protein Remove Trials
article thumbnail

Alzheimer’s patients’ cognition improves with Sargramostim (GM-CSF), new study shows

Scienmag

Clinical trial participants saw memory-enhancing benefits and disease modifying activities when taking Sargramostim A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer’s disease.